SEC Form 4 · accession 0001645627-17-000088
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.027 | A | 21,410,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.027 | A | 21,412,349 | D | |
| Common Stock | Jun 30, 2017 | P | 1,000 | $0.027 | A | 21,413,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0269 | A | 21,415,349 | D | |
| Common Stock | Jun 30, 2017 | P | 1,000 | $0.027 | A | 21,416,349 | D | |
| Common Stock | Jun 30, 2017 | P | 1,000 | $0.028 | A | 21,417,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.029 | A | 21,419,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.03 | A | 21,421,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.03 | A | 21,423,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0316 | A | 21,425,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0339 | A | 21,427,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0339 | A | 21,429,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0339 | A | 21,431,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0337 | A | 21,433,349 | D | |
| Common Stock | Jun 30, 2017 | P | 3,000 | $0.0339 | A | 21,436,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.033 | A | 21,438,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.031 | A | 21,440,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0299 | A | 21,442,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0315 | A | 21,444,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.03 | A | 21,446,349 | D | |
| Common Stock | Jun 30, 2017 | P | 3,000 | $0.032 | A | 21,449,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0319 | A | 21,451,349 | D | |
| Common Stock | Jun 30, 2017 | P | 1,000 | $0.032 | A | 21,452,349 | D | |
| Common Stock | Jun 30, 2017 | P | 1,000 | $0.032 | A | 21,453,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.032 | A | 21,455,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0325 | A | 21,457,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.033 | A | 21,459,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0329 | A | 21,461,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.032 | A | 21,463,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.03 | A | 21,465,349 | D |
Table II — derivative securities
No Table II lines on this filing.